The evidence regarding CLDN18 expression in pancreatic tissues and PDAC paves promising horizons towards adopting similar approaches in the near future for patients affected by pancreatic cancer, pending the results of ongoing clinical trials. Here, CLDN18 is linked to pancreatic neoplasm.